RESULTS

A novel target of chimeric antigen receptor T-cell therapy in solid tumor (Cancer Sci, 2024)

Dr. Meng highlighted the significance of RNA-based chimeric antigen receptor T-cell (CAR-T) therapy against cancers, indicating that the challenges and future optimization directions of this treatment strategy are explored, providing new perspectives and strategies for ‘designer cell’ therapy in solid tumors.